These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3546758)

  • 21. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy.
    Neuhaus P; Bechstein WO; Blumhardt G; Steffen R; Keck H; Lemmens P; Langrehr JM; Schlag H
    Transplant Proc; 1993 Apr; 25(2):1940-1. PubMed ID: 8470234
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive quadruple drug induction therapy sensitized renal allograft recipients.
    Schleibner S; Hillebrand G; Illner WD; Höhnke C; Steitz HO; Land W
    Transplant Proc; 1987 Oct; 19(5):3752-3. PubMed ID: 3313910
    [No Abstract]   [Full Text] [Related]  

  • 26. [T-cell oriented therapy concept in the treatment of rejection following liver transplantation].
    Kremer B; Henne-Bruns D; Kraemer-Hansen H; Harfmann P; Kuhlencordt R; Schröder S
    Helv Chir Acta; 1989 Dec; 56(4):521-5. PubMed ID: 2632478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
    Thomas J; Whitley T; Carver M; Thomas F
    Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute renal failure after heart transplantation and cyclosporine therapy.
    McGiffin DC; Kirklin JK; Naftel DC
    J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of cyclosporine A in combination with low-dose corticosteroids and azathioprine in liver transplantation.
    Gugenheim J; Samuel D; Saliba F; Castaing D; Bismuth H
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):366-8. PubMed ID: 3291269
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic immunosuppression in cardiac transplantation.
    Robinson JA; O'Connell JB
    Ann Clin Lab Sci; 1986; 16(3):209-13. PubMed ID: 3521445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.
    Gilbert EM; Renlund DG; O'Connell JB; Eiswirth CC; Rothstein G; Gay WA; Bristow MR
    J Heart Transplant; 1987; 6(6):369-74. PubMed ID: 3320307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RATG: implications for nursing care in organ transplantation.
    Pezze JL
    Crit Care Nurse; 1990 Oct; 10(9):18-9, 22, 24. PubMed ID: 2225911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 38. The price of immunotherapy.
    Penn I
    Curr Probl Surg; 1981 Nov; 18(11):681-751. PubMed ID: 6797793
    [No Abstract]   [Full Text] [Related]  

  • 39. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies in immunosuppression.
    Friend PJ
    Ann Acad Med Singap; 1991 Jul; 20(4):503-6. PubMed ID: 1799264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.